Can PET/CT substitute for bone scintigraphy in assessment of bone metastases in lung cancer patients?

被引：0
|
作者：
Watanabe, H. [1 ]
Monzawa, S. [1 ]
Adachi, S. [1 ]
Hamanaka, A. [1 ]
Kitamura, Y. [1 ]
Izaki, K. [1 ]
Okada, M. [1 ]
Satouchi, M. [1 ]
Negoro, S. [1 ]
Takada, Y. [1 ]
机构：
[1] Hyogo Med Ctr Adults, Akashi, Hyogo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7203
引用
收藏
页码：414S / 414S
页数：1
相关论文
共 50 条
  • [21] Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT
    Meltem Caglar
    Murat Tuncel
    Egemen Yildiz
    Erdem Karabulut
    [J]. Annals of Nuclear Medicine, 2020, 34 : 932 - 941
  • [22] Diagnostic performance of 11C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer
    Kitajima, Kazuhiro
    Fukushima, Kazuhito
    Yamamoto, Shingo
    Kato, Takashi
    Odawara, Soichi
    Takaki, Haruyuki
    Fujiwara, Masayuki
    Yamakado, Koichiro
    Nakanishi, Yukako
    Kanematsu, Akihiro
    Nojima, Michio
    Hirota, Shozo
    [J]. NAGOYA JOURNAL OF MEDICAL SCIENCE, 2017, 79 (03): : 387 - 399
  • [23] Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer
    Al-Muqbel, Kusai M.
    Yaghan, Rami J.
    [J]. MEDICINE, 2016, 95 (21)
  • [24] SPECT/CT, PET/CT, and PET/MRI for Assessment of Bone Metastases
    Zamani-Siahkali, Nazanin
    Mirshahvalad, Seyed Ali
    Farbod, Abolfazl
    Divband, Ghasemali
    Pirich, Christian
    Veit-Haibach, Patrick
    Cook, Gary
    Beheshti, Mohsen
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (03) : 356 - 370
  • [25] Comparison of 18FDG PET/PET-CT and bone scintigraphy for detecting bone metastases in patients with nasopharyngeal cancer: a meta-analysis
    Xu, Chuanhui
    Zhang, Ruiming
    Zhang, Huanlei
    Zhang, Zhenyan
    [J]. ONCOTARGET, 2017, 8 (35) : 59740 - 59747
  • [26] Detection of bone metastases in thyroid cancer patients:: Bone scintigraphy or 18F-DG PET?
    Phan, Ha T. T.
    Jager, Pieter L.
    Plukker, John T. M.
    Wolffenbuttel, Bruce H. R.
    Dierckx, Rudi A.
    Links, Thera P.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2007, 28 (08) : 597 - 602
  • [27] Diagnostic performance of PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis
    Niikura, Naoki
    Hashimoto, Jun
    Kazama, Toshiki
    Koizumi, Jun
    Ogiya, Rin
    Terao, Mayako
    Oshitanai, Risa
    Morioka, Toru
    Tuda, Banri
    Okamura, Takuho
    Saito, Yuki
    Imai, Yutaka
    Tokuda, Yutaka
    [J]. CANCER RESEARCH, 2015, 75
  • [28] Prospective comparative study of 18F-sodium fluoride PET/CT and planar bone scintigraphy for treatment response assessment of bone metastases in patients with prostate cancer
    Fonager, Randi Fuglsang
    Zacho, Helle Damgaard
    Langkilde, Niels Christian
    Fledelius, Joan
    Ejlersen, June Anita
    Hendel, Helle Westergreen
    Haarmark, Christian
    Moe, Mette
    Mortensen, Jesper Carl
    Jochumsen, Mads Ryo
    Petersen, Lars Jelstrup
    [J]. ACTA ONCOLOGICA, 2018, 57 (08) : 1063 - 1069
  • [29] The Impact of SPECT/CT for Excluding Bone Metastases in Patients with Equivocal Bone Scintigraphy
    Nascimento, B. B.
    Santos, A. O.
    Amorim, B. J.
    Lima, M. C.
    Etchebehere, E. C.
    Souza, J. P.
    Martins, G. F.
    Baracat, M. L.
    Altemani, J. M.
    Ramos, C. D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S590 - S590
  • [30] Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT
    Stefan Krüger
    Andreas K. Buck
    Felix M. Mottaghy
    Ellen Hasenkamp
    Sandra Pauls
    Christian Schumann
    Thomas Wibmer
    Tobias Merk
    Vinzenz Hombach
    Sven N. Reske
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1807 - 1812
12345